Valencia (Spain), January 26, 2012
Naturex posts its Annual Sales 2011
(1st January to 31 December 2011)
The invested company performs an excellent year of growth in 2011.
Annual sales objective achieved +12.3% organic growth at constant scope and currency
Full transcription of Naturex's results note
Avignon (France), 25 January 2012 - NATUREX, NATUREX, world leader in specialty plant- based ingredients, presents its annual consolidated sales the year 2011:
In million euros - Non-audited figures
Revenues | 2011 | 2010 | Var. % | Var. % constant currency |
1st quarter | 64,021 | 51,611 | 24.0% | 17.5% |
2nd quarter | 63,904 | 60,478 | 5.7% | 9.3% |
3rd quarter | 63,226 | 58,472 | 8.1% | 12.0% |
4th quarter (excluding Burgundy) | 59,718 | 55,746 | 7.1% | 11.1% |
Annual sales at constant scope | 250,869 | 226,307 | 10.9% | 12.3% |
Integration of Burgundy | 2,7 | - | - | |
4th quarter (new scope) | 62,418 | 55,746 | 12.0% | |
Annual sales at new scope | 253,568 | 226,307 | 12.0% |
2011 was a further year of strong growth for NATUREX, which
recorded excellent levels of activity over all markets and in
all geographic areas where the Group is established.
In October 2011, NATUREX performed the acquisition of
BURGUNDY, specialised in the production and marketing of
plant extracts for the nutraceutical, pharmaceutical and
cosmetics industries, which sales have been consolidated from
1st October 2011.
Thus the sales generated over the year 2011 amounted to 253.6
million euros, an increase of
12.0%. At constant scope and exchange rate, the growth in
sales was 12.3%, in compliance with the published annual
growth objective.
The activity of the 4th quarter of 2011 was in the same
growth dynamic as the previous quarters and the integration
of the activities of BURGUNDY within NATUREX generated
additional revenue of
2.7 million euros. The sales for the 4th quarter of 2011 thus
amounted to 62.4 million euros, up
12.0%.
Strong growth of the three markets around a widened product
range
In million euros - Non-audited figures | ||||
Revenues | 2011* | 2010 | share of turnover % | var.% |
Food & Beverage | 153,412 | 137,108 | 60.5% | 11.9% |
Nutrition & Health | 84,496 | 75,523 | 33.3% | 11.9% |
Personal Care | 3,008 | 2,709 | 1.2% | 11.0% |
Miscellaneous and toll extraction | 12,652 | 10,967 | 5.0% | 15.4% |
* New scope: Integration of the turnover of BURGUNDY over the 4th quarter 2011
Growth was good in the different markets, the integration of
the activities of BURGUNDY enabled to complete the offer in
the fields of Nutrition & Health and Personal Care.
• The Food & Beverage activity generated a turnover of 153.4
million euros, up 11.9%;
• The Nutrition & Health activity increased by 11.9%, for a
turnover of 84.5 million euros and includes 2.3 million euros
from the nutraceuticals activity of BURGUNDY;
• The Personal Care activity recorded a turnover of 3.0
million euros, up 11.0% and includes
0.4 million euros of sales generated by BURGUNDY
Dynamism of all geographic areas
In million euros - Non-audited figures | ||||
Revenues | 2011* | 2010 | share of turnover % | var.% |
Europe / Africa | 132,013 | 117,718 | 52.1% | 12.1% |
Americas | 92,708 | 84,107 | 36.6% | 10.2% |
Asia / Oceania | 28,847 | 24,482 | 11.4% | 17.8% |
* New scope: Integration of the turnover of BURGUNDY over the 4th quarter 2011
With commercial coverage widened to 18 locations, including 3
openings of commercial offices over the year, NATUREX has not
only strengthened its positions worldwide, but has also
created real proximity with local and regional customers,
enabling it to catch the growth of both mature markets and
emerging markets:
• The Europe/Africa zone recorded a growth of 12.1% over the
period, confirming the solidity of the European market in
spite of the difficult macroeconomic context;
• The Americas zone continues to progress, supported by the
dynamism of sales in North
America and the acceleration of sales in Latin America,
particularly in Brazil;
• The Asia/Oceania zone recorded good performances, driven by
strong sales growth in Asia and a buoyant activity in
Australia over the last two quarters of the year.
The emerging markets of Eastern Europe, Asia, Latin America,
Africa and the Middle East which represented 14% of the
Group's sales over 2011, compared with less than 10% one year
previously, offer highly promising development prospects.
"We are very satisfied with this excellent year of
growth, marked by the positive orientation of all of our
activities and geographic zones. The integration of BURGUNDY
is now on the road to completion and our teams are working
actively to quickly develop the commercial synergies."
declared Jacques Dikansky, Chief Executive Officer and
Founder of NATUREX.
"With our strengthened geographic positioning, the
highly favourable acceptance of our new product ranges and
our industrial and scientific expertise, we are confident in
our ability to continue to outperform the future growth of
our markets."
ANNEXE
Historical data (constant scope - excluding sales integration
of BURGUNDY)
• Quarterly sales breakdown
Revenues | 2011 | 2010 | Var. % | Var. % constant currency |
1st quarter | 64,021 | 51,611 | 24.0% | 17.5% |
2nd quarter | 63,904 | 60,478 | 5.7% | 9.3% |
3rd quarter | 63,226 | 58,472 | 8.1% | 12.0% |
4th quarter (excluding Burgundy) | 59,718 | 55,746 | 7.1% | 11.1% |
Annual sales at constant scope | 250,869 | 226,307 | 10.9% | 12.3% |
• Sales breakdown by market
Revenues | 2011 | 2010 | Share of turnover % | var.% | var.% constant |
currency | |||||
Food & Beverage | 153,254 | 137,108 | 61.1% | 11.8% | 11.1% |
Nutrition & Health | 82,241 | 75,523 | 32.8% | 8.9% | 14.2% |
Personal Care | 2,646 | 2,709 | 1.1% | -2.3% | 2.0% |
Miscellaneous and toll extraction | 12,728 | 10,967 | 5.1% | 16.1% | 17.1% |
• Sales breakdown by geographic region
Revenues | 2011 | 2010 | share of | var.% | var.% |
turnover % | constant currency | ||||
Europe / Africa | 129,789 | 117,718 | 51.7% | 10.3% | 9.3% |
Americas | 92,515 | 84,107 | 36.9% | 10.0% | 16.6% |
Asia / Oceania | 28,565 | 24,482 | 11.4% | 16.7% | 12.1% |
Receive all financial information on NATUREX by email free of
charge by registering at:
www.naturex.com
Upcoming publications and events
• Annual results 2011: 28 March 2012
• Midcap Event Brussels: 29-30 March 2012
• SFAF analysts meeting - Paris: 2 April 2012
Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps).
Number of shares comprising the capital: 7,705,580
6,718,272 ordinary shares (ISIN FR0000054694)
987,308 preferred shares (ISIN FR0010833251)
ISIN: FR0000054694 (NRX) - Reuters: NATU.PA - Bloomberg: NRX:FP.
About Naturex
NATUREX is a global leader in specialty plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX's head office is based in Avignon, France. The company employs more than 1,000 people with high-performance manufacturing operations across 13 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has a global presence through a dedicated network of sales offices in
18 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil and Mexico).
NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
Naturex contacts Actus Finance contacts
Jacques Dikansky
President and CEO
Tel: +33 (0)4 90 23 96 89 naturex@naturex.com
Anne Catherine Bonjour
Press Relations
Tel: + 33 (0)1 53 67 36 93 acbonjour@actus.fr
Thierry Lambert
Vice-president and CFO Tel: +33 (0)4 90 23 96 89
Jérôme Fabreguettes-Leib
Investor Relations
Tel: + 33 (0)1 77 35 04 36 jfl@actus.fr
Carole Alexandre
Investor Relations
Tel. +33 (0) 4 90 23 78 28 c.alexandre@naturex.com
distribué par | Ce noodl a été diffusé par Natraceutical SA et initialement mise en ligne sur le site http://www.natraceuticals.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-27 14:48:39 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
Documents associés | |
Naturex: 2011 Revenues note |